Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Arvinas Holding Company, Llc (ARVN)  
$31.36 0.21 (0.67%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 68,788,000
Market Cap: 2.16(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $14.19 - $52.31
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Arvinas is a biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies to degrade disease-causing proteins. Co. is developing ARV-110, a proteolysis targeting chimeras (PROTAC) targeted protein degrader targeting the androgen receptor protein for the treatment of men with metastatic castration-resistant prostate cancer. Co. is also developing ARV-471, a PROTAC targeted protein degrader targeting the estrogen receptor protein, or ER, for the treatment of patients with locally advanced or metastatic ER positive / HER2 negative breast cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 10,298 10,298 11,622 21,554
Total Sell Value $484,521 $484,521 $516,810 $859,747
Total People Sold 4 4 4 4
Total Sell Transactions 4 4 5 9
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 174
  Page 4 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Taylor Ian Chief Scientific Officer   •       –      –    2021-08-16 4 AS $86.84 $1,745,917 D/D (20,000) 78,645 -7%     
   Taylor Ian Chief Scientific Officer   •       –      –    2021-08-16 4 OE $16.00 $320,000 D/D 20,000 98,645     -
   Margus Bradley Albert Director   –       •      –    2021-08-13 4 S $90.03 $524,695 I/I (5,828) 31,940 11%     
   Peck Ronald Chief Medical Officer   •       –      –    2021-08-12 4 S $90.54 $123,399 D/D (1,363) 5,402 13%     
   Peck Ronald Chief Medical Officer   •       –      –    2021-08-12 4 OE $0.00 $0 D/D 4,011 6,765     -
   Margus Bradley Albert Director   –       •      –    2021-08-11 4 S $90.03 $450,150 I/I (5,000) 37,768 13%     
   Houston John G President and CEO   •       •      –    2021-08-02 4 AS $96.96 $4,492,415 D/D (45,922) 827,643 -26%     
   Houston John G President and CEO   •       •      –    2021-08-02 4 OE $16.00 $734,752 D/D 45,922 873,565     -
   Cassidy Sean A Chief Financial Officer   •       –      –    2021-07-28 4 AS $100.00 $1,724,200 D/D (17,242) 158,249 -27%     
   Cassidy Sean A Chief Financial Officer   •       –      –    2021-07-28 4 OE $16.00 $275,872 D/D 17,242 175,491     -
   Peck Ronald Chief Medical Officer   •       –      –    2021-06-30 4 AS $76.69 $1,533,800 D/D (20,000) 2,754 19%     
   Peck Ronald Chief Medical Officer   •       –      –    2021-06-30 4 OE $47.38 $947,600 D/D 20,000 22,754     -
   Houston John G President and CEO   •       •      –    2021-06-10 4 AS $80.52 $3,576,263 D/D (43,886) 827,643 -1%     
   Houston John G President and CEO   •       •      –    2021-06-10 4 OE $16.00 $702,176 D/D 43,886 871,529     -
   Houston John G President and CEO   •       •      –    2021-06-09 4 AS $80.15 $56,104 D/D (700) 827,643 8%     
   Houston John G President and CEO   •       •      –    2021-06-09 4 OE $16.00 $11,200 D/D 700 828,343     -
   Taylor Ian Chief Scientific Officer   •       –      –    2021-04-05 4 AS $66.01 $1,670,143 D/D (25,000) 78,645 35%     
   Taylor Ian Chief Scientific Officer   •       –      –    2021-04-05 4 OE $16.00 $400,000 D/D 25,000 103,645     -
   Cassidy Sean A Chief Financial Officer   •       –      –    2021-03-02 4 S $77.45 $172,015 D/D (2,221) 158,249 -4%     
   Cassidy Sean A Chief Financial Officer   •       –      –    2021-03-02 4 OE $0.00 $0 D/D 4,792 160,470     -
   Houston John G President and CEO   •       •      –    2021-03-02 4 S $77.45 $628,503 D/D (8,115) 827,643 -4%     
   Houston John G President and CEO   •       •      –    2021-03-02 4 OE $0.00 $0 D/D 17,510 835,758     -
   Taylor Ian Chief Scientific Officer   •       –      –    2021-03-02 4 S $77.45 $69,240 D/D (894) 78,645 -4%     
   Taylor Ian Chief Scientific Officer   •       –      –    2021-03-02 4 OE $0.00 $0 D/D 2,685 79,539     -
   Taylor Ian Chief Scientific Officer   •       –      –    2021-02-19 4 OE $16.00 $103,296 D/D 6,456 76,854     -
  174 Records found
  1  2  3  4  5  6  7   
  Page 4 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us